Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kentaro Nakata"'
Autor:
Riley Kahan, BS, Nader Abraham, MD, Min Zhang, MD, Valery Novokhatny, PhD, Isaac Alderete, BS, Paul Cray, PhD, Fengming Chen, MD, PhD, Qimeng Gao, MD, Greta Cywinska, BS, Ryan Neill, Kentaro Nakata, MD, PhD, Ahmed Hassan, MD, Caroline Rush, BS, Jude Penaflor, BS, Justin J. Pollara, PhD, Matthew G. Hartwig, MD, Benjamin Hughes, PhD, Andrew S. Barbas, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 8, p e1665 (2024)
Background. The clinical success of liver transplantation has led to increased demand, requiring further expansion of the donor pool. Therapeutic interventions to optimize organs from donation after circulatory death (DCD) have significant potential
Externí odkaz:
https://doaj.org/article/198c4a09b7c04981b262f3cc59270a46
Autor:
Nader Abraham, MBBS, Qimeng Gao, MD, Riley Kahan, MBS, Isaac S. Alderete, BS, Bangchen Wang, MD, PhD, David N. Howell, MD, PhD, Imran J. Anwar, MD, Joseph M. Ladowski, MD, PhD, Kentaro Nakata, MD, Ethan Jarrett, BS, Kendall Hlewicki, BS, Greta Cywinska, BA, Ryan Neill, Charles Aardema, MS, David A. Gerber, MD, Prabir Roy-Chaudhury, MD, Benjamin A. Hughes, PhD, Matthew G. Hartwig, MD, Andrew S. Barbas, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 6, p e1633 (2024)
Background. Ex vivo kidney perfusion is an evolving platform that demonstrates promise in preserving and rehabilitating the kidney grafts. Despite this, there is little consensus on the optimal perfusion conditions. Hypothermic perfusion offers limit
Externí odkaz:
https://doaj.org/article/316cabc23e6d450fbb2fb8786b4651a6
Autor:
Yin Min Thu, Ken Suzawa, Shuta Tomida, Kosuke Ochi, Shimpei Tsudaka, Fumiaki Takatsu, Keiichi Date, Naoki Matsuda, Kazuma Iwata, Kentaro Nakata, Kazuhiko Shien, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/e0efbab046e74723a3b73a473405b7ce
Autor:
Kei Namba, Ken Suzawa, Kazuhiko Shien, Akihiro Miura, Yuta Takahashi, Shunsaku Miyauchi, Kota Araki, Kentaro Nakata, Shuta Tomida, Shin Tanaka, Kentaroh Miyoshi, Shinji Otani, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Junichi Soh, Masaomi Yamane, Shinichi Toyooka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract One-step nucleic acid amplification (OSNA) is a rapid intraoperative molecular detection technique for sentinel node assessment via the quantitative measurement of target cytokeratin 19 (CK19) mRNA to determine the presence of metastasis. It
Externí odkaz:
https://doaj.org/article/fa1c94149c674f01844aaa63a9048ad2
Autor:
Kentaro Nakata, Mikio Okazaki, Tomohisa Sakaue, Rie Kinoshita, Yuhei Komoda, Dai Shimizu, Haruchika Yamamoto, Shin Tanaka, Ken Suzawa, Kazuhiko Shien, Kentaroh Miyoshi, Hiromasa Yamamoto, Toshiaki Ohara, Seiichiro Sugimoto, Masaomi Yamane, Akihiro Matsukawa, Masakiyo Sakaguchi, Shinichi Toyooka
Publikováno v:
Bioengineering, Vol 9, Iss 11, p 673 (2022)
(1) Background: Lung ischemia–reperfusion (IR) injury increases the mortality and morbidity of patients undergoing lung transplantation. The objective of this study was to identify the key initiator of lung IR injury and to evaluate pharmacological
Externí odkaz:
https://doaj.org/article/e204d0148e6c4444960fbfe9e8c4a12d
Publikováno v:
In Fusion Engineering and Design September 2023 194
Publikováno v:
The Annals of Thoracic Surgery.
Autor:
Dai Shimizu, Mikio Okazaki, Seiichiro Sugimoto, Rie Kinoshita, Kentaro Nakata, Shin Tanaka, Kohei Hashimoto, Kentaroh Miyoshi, Masaomi Yamane, Akihiro Matsukawa, Masakiyo Sakaguchi, Shinichi Toyooka
Publikováno v:
Biochemical and biophysical research communications. 629
Although bronchiolitis obliterans syndrome (BOS) is a major cause of death after lung transplantation, an effective drug therapy for BOS has not yet developed. Here, we assessed the effectiveness of a neutralizing anti-S100 calcium binding protein (S
Autor:
Kosuke Ochi, Ken Suzawa, Yin Min Thu, Fumiaki Takatsu, Shimpei Tsudaka, Yidan Zhu, Kentaro Nakata, Tatsuaki Takeda, Kazuhiko Shien, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Tadahiko Shien, Yoshiharu Okamoto, Shuta Tomida, Shinichi Toyooka
Publikováno v:
Cancer Science. 2022
Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment that mediate resistance of cancer cells to anticancer drugs. Tranilast is an antiallergic drug that suppresses the release of cytokines from various inflammatory
Autor:
Kazuhiko Shien, Tatsuaki Takeda, Kei Namba, Shuta Tomida, Toshiaki Sendo, Yoshihisa Kitamura, S. Miyauchi, Shinichi Toyooka, Kentaro Nakata, Junichi Soh, Ken Suzawa, Akihiro Miura, Hiromasa Yamamoto, Tadahiko Shien, Kota Araki
Publikováno v:
Cancer Science
Molecular‐targeted therapies directed against human epidermal growth factor receptor 2 (HER2) are evolving for various cancers. Neratinib is an irreversible pan‐HER tyrosine kinase inhibitor and has been approved by the FDA as an effective drug f